Women with Crohn disease who use oral contraceptives for more than 1 year have an increased risk of surgery.
The biosimilar has also been approved for Crohn's disease, ulcerative colitis, and ankylosing spondylitis.
Patients with Crohn disease who ate high-fiber foods were 40% less likely to have a disease flare.
A condition prone to recurrence, Crohn disease has a complicated presentation and pathophysiology, but multiple treatment options are available.
Entyvio can be used to treat ulcerative colitis and Crohn disease in adults who did not have success with other treatments.
People with airway diseases are more likely to have inflammatory bowel disease.
The FDA has approved vedolizumab for patients with inadequate response to conventional therapies.
Early monotherapy with such anti-TNF-alpha agents as infliximabor and adalimumab may produce better overall clinical and growth outcomes.
Greatest reductions observed for fiber derived from fruits.
Once-daily thalidomide improved clinical remission at eight weeks for children with refractory Crohn's disease
Adalimumab induction and maintenance was shown to be safe and effective for children with moderate-to-severe Crohn's.
Which serologic measure of inflammation is the most cost-effective and reliable when monitoring inflammatory disease?
What first appeared to be infectious esophagitis ended up being a lifelong diagnosis for a young woman.